3SBio Inc. Google Group

Positive Phase 3 results of an erectile dysfunction (ED) drug

tanumoydutta1...@gmail.com (tanu) — Thu, 19 Nov 2009 12:33:36 UT

VIVUS Inc. (VVUS) reported positive results for Avanafil, their
erectile dysfunction (ED) drug. New BioMedicine had issued a report
with positive coverage of this event on May 5, 2009. Stock up 111.7%
from the date of our coverage till after the news announcement. To
know about the disease, the drug, the market potential, the

Positive data from an early stage trial of a sarcoma drug.........

sudipbanerjeeos...@gmail.com (babu) — Thu, 12 Nov 2009 12:24:41 UT

Threshold Pharmaceuticals, Inc. (THLD) reported positive results for
TH-302, their sarcoma drug. New BioMedicine issued positive coverage
of this event on August 18, 2009. The stock is up 115% from the date
of our coverage. To read our report, which covers the disease, the
drug, the market potential, the competition, etc., access it FREE at:

FDA Decision on approval of a small cap company's drug for Anemia on June 29th

debapriya2...@yahoo.com (debapriyadutta) — Mon, 29 Jun 2009 12:29:09 UT

The upcoming FDA Decision date on JUNE 29th (TODAY) for this small cap
company's drug for Anemia patients will affect SSRX directly. To read
about HOW it will affect SSRX and about our opinion on whether the
drug will be approved or not, along with details of the company, the
drug, the disease, the competitors, the market and the sales potential

Upcoming FDA Approval of a small cap company's drug for Anemia patients

ritushre...@gmail.com (ritushreeya) — Sat, 27 Jun 2009 09:48:28 UT

The upcoming FDA Decision date on JUNE 29th (Monday) for this small
cap company's drug for Anemia patients will affect SSRX directly. To
read about HOW it will affect SSRX and about our opinion on whether
the drug will be approved or not, along with details of the company,
the drug, the disease, the competitors, the market and the sales

Upcoming FDA Decision on June 29th on approval of a small cap company's drug for Anemia patients

kamalika4...@yahoo.com (kamalika4321) — Fri, 26 Jun 2009 11:52:27 UT

Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July

biswas_debar...@yahoo.com (Debarati) — Thu, 25 Jun 2009 11:22:15 UT

A small cap company is going to be presenting data on their
Alzheimer's drug at the Alzheimer's conference in July. If the trials
data is positive, it brings the company one step closer to the
approval of a breakthrough treatment for Alzheimer's disease. To find
out about the company, the drug, how the drug works, who are the other

Upcoming FDA Panel recommendation on June 26th of a small cap company's Opthalmic (eye) drug.

lopa86...@gmail.com (lopamudra) — Wed, 24 Jun 2009 13:06:18 UT

FDA Panel meeting on Friday (June 26th) to recommend approval on a
small cap company's opthalmic drug. If the drug is eventually
approved, the Peak Sales of this drug could reach over 100% of the
current market cap of the company. To read about the drug, the
disease, the market, and how the drug compares to competitors, get a

Upcoming FDA decision on the approval of a small cap company's Depression drug

lopa86...@gmail.com (lopamudra) — Mon, 22 Jun 2009 13:20:34 UT

The FDA approval decision date for a small cap company's Depression
drug is coming up in July. If approved, this could become a
breakthrough treatment for Depression and take a sizable bite out of
major players like Forest Labs and Wyeth's market share. To find out
what the chances are of this new drug being approved, how the drug

High Volume and down... why?

erede...@gmail.com — Tue, 23 Sep 2008 18:27:34 UT

What is happening with this stock? Seems like it should be on the up
and up, but its being very volatile. Any explanations?

Long term strategy

geowo...@gmail.com — Fri, 06 Jun 2008 18:39:44 UT

3SBio is selling Amgen and Biogen's drugs to the world's biggest, but
not the world's richest market...at least not yet. That makes for very
strong promise for the very long term IMHO.

China Investment Guidance #1 Newsletter, China Stock Digest

New investing guidebook, “Becoming Your Own China Stock Guru” is

Re: Stock buyback = Short-squeeze = Payday for longs

jmilh...@gmail.com — Thu, 20 Mar 2008 14:00:49 UT

Yep, and kudos to 3sbio for buying back at a great price.
Market cap on this deserves at least $300M, so I can't imagine who
would be short on this stock with PPS in the mid $7's, but you are
right that there could be a short squeeze going on.

Stock buyback = Short-squeeze = Payday for longs

jcarc...@gmail.com — Wed, 19 Mar 2008 23:42:56 UT

Amen, a stock buy-back, enjoy the short squeeze. --Longs finally get
paid.

position: overweight,strong buy, long

whats deal with ssrx ?

prashantpri...@yahoo.com — Thu, 24 Jan 2008 01:43:10 UT

I bought ssrx considering his fundament and pipeline.

I dont know company is not bringing any news!!!

Where is CEO ? what he does ?

SSRX is still worth investing.

w...@hotmail.com — Tue, 27 Nov 2007 20:48:58 UT

even though SSRX dropped again today, i still believe the fundementals
of the firm are good with competitive products and high demands. Do
not panic. It is better to hold stocks for a while. Do not let
speculators have chance to scare us away in order to take in cheaper
stocks and pull them back in future. Something strange here dont make

Re: Why SSRX dropping at such a high percentage for a stock under $20

eed2sellingst...@gmail.com — Sat, 24 Nov 2007 22:05:36 UT

i agree with you on that!

i bought at 13.80 before the reports....
sold the next day at 16.40 and then it came down

bought in again at 13.60

now i will hold again ^^